Literature DB >> 22252101

Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis.

Cun S Fang1, Ying C Wang, Tao H Zhang, Jing Wu, Wei Wang, Chun Wang, Ming Y Zhang.   

Abstract

BACKGROUND: It is well known that pulmonary alveolar proteinosis(PAP) is characterised by accumulation of surfactant lipids and proteins within airspaces. However, few previous data describe the serum lipid levels associated with PAP.
MATERIALS AND METHODS: We retrospectively reviewed 25 patients with idiopathic PAP(iPAP). The serum lipid levels of patients with idiopathic PAP were compared with those of the healthy volunteers. In patients and healthy subjects, the LDL-C/HDL-C ratios were 2.94 ± 1.21 and 1.60 ± 0.70, respectively (p < 0.001), HDL-C were 1.11 ± 0.27 and 1.71 ± 0.71 respectively (p < 0.001). The values of LDL-C correlated significantly with those of PaO2 and PA-aO2 (r = -0.685, p = 0.003, and r = 0.688, p = 0.003, respectively). The values of LDL-C/HDL-C ratios also correlated with PaO2 levels and PA-aO2 levels (r = -0.698, p = 0.003, and r = 0.653, p = 0.006, respectively). 11 and 13 patients experienced respectively a decline in TC and LDL-C levels following whole lung lavage(WLL), the median decline was 0.71 mmol/L(p < 0.009) and 0.47 mmol/L(p < 0.003), respectively.
CONCLUSIONS: the serum lipid levels, especially the levels of LDL-C and LDL-C/HDL-C, may reflect the severity of the disease in PAP patients, and predict the therapeutic effect of WLL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252101      PMCID: PMC3271981          DOI: 10.1186/1476-511X-11-12

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  26 in total

Review 1.  Therapy options in pulmonary alveolar proteinosis.

Authors:  Maurizio Luisetti; Zamir Kadija; Francesca Mariani; Giuseppe Rodi; Ilaria Campo; Bruce C Trapnell
Journal:  Ther Adv Respir Dis       Date:  2010-07-20       Impact factor: 4.031

2.  Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.

Authors:  Riikka Vikstedt; Dan Ye; Jari Metso; Reeni B Hildebrand; Theo J C Van Berkel; Christian Ehnholm; Matti Jauhiainen; Miranda Van Eck
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-14       Impact factor: 8.311

3.  Whole-lung lavage for pulmonary alveolar proteinosis.

Authors:  Gaëtane Michaud; Chakravarthy Reddy; Armin Ernst
Journal:  Chest       Date:  2009-12       Impact factor: 9.410

Review 4.  Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction.

Authors:  Sara R Greenhill; Darrell N Kotton
Journal:  Chest       Date:  2009-08       Impact factor: 9.410

Review 5.  GM-CSF pathway correction in pulmonary alveolar proteinosis.

Authors:  Sabina A Antoniu
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

6.  An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.

Authors:  Saiprakash B Venkateshiah; Tom D Yan; Tracey L Bonfield; Mary Jane Thomassen; Moulay Meziane; Carmen Czich; Mani S Kavuru
Journal:  Chest       Date:  2006-07       Impact factor: 9.410

7.  Ameliorating effect of capsaicin on alterations in lipid metabolism during mice lung carcinoma.

Authors:  P Anandakumar; S Jagan; S Kamaraj; G Ramakrishnan; J Binu Clara; D Pathitha; T Kavitha; T Devaki
Journal:  Arch Pharm Res       Date:  2009-03-13       Impact factor: 4.946

Review 8.  Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.

Authors:  Bruce C Trapnell; Brenna C Carey; Kanji Uchida; Takuji Suzuki
Journal:  Curr Opin Immunol       Date:  2009-09-30       Impact factor: 7.486

9.  Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.

Authors:  Makoto Kobayashi; Tamotsu Takeuchi; Yuji Ohtsuki
Journal:  Pathol Int       Date:  2008-03       Impact factor: 2.534

10.  Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment.

Authors:  David Gallego-Ortega; Ana Ramirez de Molina; Maria Angeles Ramos; Fatima Valdes-Mora; Maria Gonzalez Barderas; Jacinto Sarmentero-Estrada; Juan Carlos Lacal
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more
  3 in total

Review 1.  The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.

Authors:  Paul D Blanc; Isabella Annesi-Maesano; John R Balmes; Kristin J Cummings; David Fishwick; David Miedinger; Nicola Murgia; Rajen N Naidoo; Carl J Reynolds; Torben Sigsgaard; Kjell Torén; Denis Vinnikov; Carrie A Redlich
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

2.  Correlation of Lipid Ratios With the Severity of Pulmonary Alveolar Proteinosis: A Cross-Sectional Study.

Authors:  Xin Yan; Yujuan Gao; Qi Zhao; Xiaohua Qiu; Mi Tian; Jinghong Dai; Yi Zhuang
Journal:  Front Nutr       Date:  2021-03-18

3.  Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis.

Authors:  Cormac McCarthy; Elinor Lee; James P Bridges; Anthony Sallese; Takuji Suzuki; Jason C Woods; Brian J Bartholmai; Tisha Wang; Claudia Chalk; Brenna C Carey; Paritha Arumugam; Kenjiro Shima; Elizabeth J Tarling; Bruce C Trapnell
Journal:  Nat Commun       Date:  2018-08-07       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.